Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 151 to 175 of 2013

TitleReference numberPublishedLast updated
Olaparib for treating BRCA mutation-positive HER2-negative advanced breast cancer after chemotherapyTA1040
Ganaxolone for treating seizures caused by CDKL5 deficiency disorder in people 2 years and overTA1033
Selpercatinib for advanced thyroid cancer with RET alterations after treatment with a targeted cancer drug in people 12 years and overTA1038
Selpercatinib for advanced thyroid cancer with RET alterations untreated with a targeted cancer drug in people 12 years and overTA1039
Artificial intelligence (AI)-derived software to analyse chest X-rays for suspected lung cancer in primary care referrals: early value assessmentHTG696
Elacestrant for treating oestrogen receptor-positive HER2-negative advanced breast cancer with an ESR1 mutation after endocrine treatmentTA1036
Pembrolizumab for adjuvant treatment of resected non-small-cell lung cancerTA1037
Intravascular lithotripsy to treat calcified coronary arteries during percutaneous coronary interventionHTG740
Tobacco: preventing uptake, promoting quitting and treating dependenceNG209
Epilepsies in children, young people and adultsNG217
Gambling-related harms: identification, assessment and managementNG248
Vadadustat for treating symptomatic anaemia in adults having dialysis for chronic kidney diseaseTA1035
Niraparib with abiraterone acetate and prednisone for untreated hormone-relapsed metastatic prostate cancer (terminated appraisal)TA1032
Anhydrous sodium thiosulfate for preventing hearing loss caused by cisplatin chemotherapy in people 1 month to 17 years with localised solid tumoursTA1034
Vamorolone for treating Duchenne muscular dystrophy in people 4 years and overTA1031
Maternal and child nutrition: nutrition and weight management in pregnancy, and nutrition in children up to 5 yearsNG247
Bimekizumab for treating moderate to severe hidradenitis suppurativa (terminated appraisal)TA1028
Andexanet alfa for reversing anticoagulation in people with intracranial haemorrhage (terminated appraisal)TA1029
Durvalumab with chemotherapy before surgery (neoadjuvant) then alone after surgery (adjuvant) for treating resectable non-small-cell lung cancerTA1030
Andexanet alfa for reversing anticoagulation from apixaban or rivaroxabanTA697
Artificial intelligence (AI) technologies to help detect fractures on X-rays in urgent care: early value assessmentHTG739
Digitally enabled therapies for adults with depression: early value assessmentHTG675
Tebentafusp for treating advanced uveal melanomaTA1027
Electrically stimulated intravesical therapy for interstitial cystitis or overactive bladder in adultsHTG738
Transperineal laser ablation for treating lower urinary tract symptoms of benign prostatic hyperplasiaHTG737

Results per page

  1. 10
  2. 25
  3. 50
  4. All